Precipio (PRPO) Net Income towards Common Stockholders Growth (3y) (2013 - 2025)
Precipio (PRPO) Net Income towards Common Stockholders Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.22% |
| 10 | Precipio | 36.29 Mn | 33.64 Mn | 3.13 Mn | 30.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.64% |
| Sep 30, 2025 | 70.82% |
| Jun 30, 2025 | 26.71% |
| Mar 31, 2025 | 42.25% |
| Dec 31, 2024 | 45.09% |
| Sep 30, 2024 | 30.44% |
| Jun 30, 2024 | 26.02% |
| Mar 31, 2024 | -12.71% |
| Dec 31, 2023 | 35.63% |
| Sep 30, 2023 | 23.90% |
| Jun 30, 2023 | -0.65% |
| Mar 31, 2023 | 22.66% |
| Dec 31, 2022 | 15.39% |
| Sep 30, 2022 | -18.78% |
| Jun 30, 2022 | 28.69% |
| Mar 31, 2022 | -40.58% |
| Dec 31, 2021 | 31.79% |
| Sep 30, 2021 | 21.53% |
| Jun 30, 2021 | 1.63% |
| Mar 31, 2021 | 37.52% |